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OBJECTIVES: To evaluate Health Related Quality of Life (HRQoL) among general
population of Quetta city, Pakistan.METHODS: The study was designed as a ques-
tionnaire-based cross sectional analysis. EuropeanQuality of Life scale (EQ-5D)was
used for assessment ofHRQoL. A total of 1500 healthy participants fromMarch 2011
to July 2011, aging 18 years and above were approached. Descriptive statistics were
used to describe demographic characteristics of the general population. Percent-
ages and frequencies were used to categorize the categorical variables, while
means and standard deviations were calculated for the continuous variables. In-
ferential statistics (Mann-Whitney and Kruskal Wallis tests) were used where ap-
propriate. HRQoLwas scored using values adapted from the UK general population
survey. All analyses were performed using SPSS 16.0. RESULTS: One thousand five
hundred questionnaires were distributed and 1255 were returned (with response
rate of 83.67%). Six hundred and forty three (51.2%) were males. Majority (n427,
34.0%)were categorized in age group of 28-37 years. Three hundred and thirty three
(26.5%) had intermediate level of education. Two hundred and ninety one (23.2%)
had monthly income of in between 10001-15000 Pakistan rupees with 828 (66.0%)
having urban residency. HRQoL was measured as 0.640.21 and VAS score was
68.7111.71. Only age and marital status, among all demographic characteristics
had significant relation with HRQoL score (p0.05). CONCLUSIONS: Results of the
present study provide the general health status of healthy population of Quetta
city, Pakistan, which could sever as baseline data for further investigations.
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OBJECTIVES: In vitro diagnostic (IVD) has a considerable health economic impact:
60% of patients’ information derives from IVD tests, but IVD makes 1% of the total
health care budget in EU (EDMA, 2010). No cost-effectiveness (CE) analyses are
available onmolecular IVD in allergy; only NICE in the UKmade a CE study IgE IVD
for peanut allergy (PA). Given the impact of PA on quality of life (QALY), accurate
diagnosis is crucial. 10%of children are considered peanut sensitised, but only 1-2%
is true positive for PA world-wide. Subjects with IgE antibodies to allergens Ara
h1-2-3 have high risk of allergic reactions (Astier, 2006). DBPCFC is the gold-stan-
dard for food-allergy diagnosis; however it is time-consuming, expensive and
might induce severe reactions in PA subjects (Nicolau, 2010). Other cheaper options
such as open challenge are also used. IVD can give clinicians a tool to decide the
need of DBPCFC (Sastre, 2010); is IVD CE per QALY (CEQ) compared to DBPCFC or
open challenge in suspected PA children in selected Asian markets (China, Japan
andKorea)?METHODS:Clinical datawas collected at Stockholm’s Sach=s Childrens
hospital (Nilsson, 2011) and from published literature. A 5-year simulation model
comparing IVD (ImmunoCap® - allergens f13, Ara h 1- 2-3-8-9) with DBPCFC or
open challenge was developed with Exel ®, to analyse CE for IVD. The sensitivity
and specificity of each diagnostics determines the percentage of patients true-
allergic, false-allergic, true-healthy and false-healthy. Results are presented from
the health care perspective. RESULTS: IgE IVD is CEQ and cost saving for children
with suspected PA in multiple countries compared to gold-standard DBPCFC or
open challenge.CONCLUSIONS: IVDisaCEQalternative toDBPCFCinselectedpatients
in multiple countries. DBPCFC might be replaced in selected cases, still being useful in
subjectswith conflicting immunological/clinical results (Codreanu, 2011).
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OBJECTIVES: A number of studies have demonstrated that theophylline could pre-
vent acute renal failure in neonates with perinatal asphyxia. No meta-analysis on
this topic, however, is available. Hence, we aimed to conduct a meta-analysis on
the efficacy of theophylline in preventing impaired renal function in such
neonates.METHODS: A systematic search was performed through following elec-
tronic databases: PubMed, ScienceDirect, Cochrane Library and Wiley Online Li-
brary from their respective inception until February 2012. The bibliography of the
retrieved studies was also reviewed. The searching keywords included: theophyl-
line, asphyxia, renal dysfunction, kidney dysfunction, renal failure, neonate, new-
born and randomized controlled trial. The inclusion criteria for study selection
were: 1) being a randomized controlled trial (RCT); 2) evaluating the effects of
theophylline on kidney function in neonates with perinatal asphyxia; and 3) re-
porting on serum creatinine (SCr) or glomerular filtration rate (GFR); and 4) being
published in English. Study quality was assessed by the Jadad scale. Results were
pooled using inverse variance-weightedmethod. Datawere analyzed using Review
Manager (RevMan) version 5.1.4.RESULTS:Altogether five RCTsmet the criteria. All
studies investigated the effect on SCr while only three of them reported the effect
on GFR. The total numbers of patients included in the evaluation of effect on SCr
and GFR were 247 and 127, respectively. Theophylline was found to significantly
reduce SCr, with the pooledmean difference in SCr being -0.32 mg/dL (95%CI: -0.52
to -0.13 mg/dL, p0.001). Likewise, it was found to significantly increase GFR, with
the pooledmean difference in GFR being 10.20ml/min (95%CI: 4.80 to 15.59ml/min,
p0.0002). CONCLUSIONS: This study suggests beneficial effects of prophylactic
theophylline on reducing kidney dysfunction in neonates with asphyxia. Due to
the small number of studies included in the analysis, however, a future meta-
analysis including more RCTs is warranted to verify these findings.
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OBJECTIVES: Despite some studies suggesting a possible association between hu-
man leukocyte antigen (HLA), HLA-B*1502 and carbamazepine induced Stevens -
Johnson syndrome (SJS) and Toxic Epidermal Necrolysis (TEN), the evidence of
association and its magnitude remain inconclusive. This study aims to systemat-
ically review and quantitatively synthesize the association between HLA-B*1502
allele and carbamazepine -induced SJS/TEN.METHODS: : A comprehensive search
was performed in databases including Pubmed, Embase, CINAHL (Cumulative In-
dex to Nursing and Allied Health Literature), IPA (International Pharmaceutical
Abstract), HuGENet (HumanGenomeEpidemiologyNetwork), Cochrane library and
reference lists of studies, without language restriction. Databases were searched
from their inception to July 2011. All studies were extracted by two independent
authors. The primary analysis was the carrier frequency ofHLA-B*1502 comparison
between carbamazepine -induced SJS/TEN case and carbamazepine tolerant con-
trol. The summary odds ratios were calculated using a random-effects model.
RESULTS: From 349 articles identified, 13 studies were included; 8 studies with 150
SJS/TEN cases and 498 matched-controls (carbamazepine tolerant control) and 5
studies with 45 SJS/TEN cases and 2,464 population-controls (general population).
We found a statistically significant association between HLA-B*1502 allele in both
groups of studies with matched-control (odds ratio (OR)  124.18, 95% confidence
interval (CI)  47.48 - 324.77) and population-control (OR  66.42, 95% CI  9.20-
480.04). Subgroup analysis in matched-control studies according to ethnicity
yielded similar and significant findings (Han-Chinese odds ratio (OR)  236.24, 95%
confidence interval (CI)  71.72 - 778.11; Thai odds ratio (OR)  54.43, 95% confi-
dence interval (CI)  16.28 – 181.96). CONCLUSIONS: We found a strong and signifi-
cant association between HLA-B*1502 and carbamazepine -induced SJS/TEN. Therefore,
HLA-B*1502allele screening shouldbeconsidered inpopulationwithhigh riskof SJS/TEN.
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OBJECTIVES: Asthma as the most common chronic disease in childhood reduces
the quality of life of children and their families. We aimed to estimate the cost of
managing childhood asthma in Iran and to examine its variability depending on
asthma severity. METHODS: The cost of asthma was estimated by building a cost
assessment model regarding the factors that influence the cost of asthma in chil-
dren including; age and sex distribution, prevalence of disease severity, level of
resource utilization depending on disease severity (3 groups of controlled, partly
controlled and uncontrolledwere defined). Themodel was comprised of bothmed-
ical (cost ofmedication, physician visit and respiratory tests) and nonmedical costs
(transportation and hoteling). Furthermore the average family income in each cat-
egory was figured and the share of asthma managing costs from the average in-
come was calculated in different groups. RESULTS: According to the model, the
total cost of childhood asthma in Iran was around 468 million dollars. Moreover,
direct medical cost represented 45% of the total costs, among which 66% account-
ing for medication cost. Direct nonmedical costs, was estimated 55% with the
majority (93%) expended on transportation. Additionally, themean annual cost per
child was approximately 541 dollars. In addition the results indicate the vast ma-
jority of patients (46%) are categorized in the uncontrolled group. CONCLUSIONS:
The cost of childhood asthma in Iran is extremely high comparing to the average
income of Iranian families in all categories of asthma severity. Considering the
high amount of transportation cost, the accessibility of asthma treatment does not
appear to be acceptable. The major source of costs is considered with the health
care system expenditures that does not necessarily result in a well-controlled dis-
ease status.
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